Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Projected Valuation Of The Artificial Intelligence (AI) In Biopharmaceuticals Market In The Coming Years?

In recent times, there has been a significant expansion in the market size of artificial intelligence (AI) in the biopharmaceuticals industry. The market is poised to swell from $1.59 billion in 2024 to $2.1 billion in 2025, marking a compound annual growth rate (CAGR) of 32.2%. Factors contributing to this growth during the historical period include improved computational capabilities, a surge in biomedical data, the emergence of precision medicine paradigm, and increasing regulatory support and guidance.

We expect to observe a tremendous surge in the size of the artificial intelligence (AI) in the biopharmaceuticals market over the upcoming years. By 2029, projections estimate it to reach $6.58 billion, with a compound annual growth rate (CAGR) of 33.0%. This substantial growth during the forecast period can be associated with strides made in computational biology, the blending of multi-modal data, the coming together of AI and life sciences, as well as regulatory support and frameworks, and principles for ethical and just AI. The forecast period will also witness major trends like the merging of multi-omics data, AI-driven drug creation and discovery, explainable AI and its acceptance by regulatory bodies, technological progresses, developments in regulations, and budding opportunities.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14251&type=smp

What Underlying Factors Are Supporting The Artificial Intelligence (AI) In Biopharmaceuticals Market Growth?

The rise in chronic diseases is anticipated to fuel the expansion of the artificial intelligence (AI) in the biopharmaceuticals market in the forthcoming days. These conditions are typically long-term and progress at a slow pace, possibly enduring for several years or even an entire lifetime. Causes include lifestyle elements, an aging demographic, genetic inclinations, and environmental determinants. AI in biopharmaceuticals is being increasingly utilized to deal with chronic diseases as it can analyze extensive and varied data sources, identify patterns, and tailor treatment plans. For example, the US Department of Health and Human Services reported in November 2023 that the new cases of chronic hepatitis B had increased by 11 percent in 2022 compared to 2021. Consequently, the rising incidence of chronic illnesses is spurring the expansion of the artificial intelligence (AI) in the biopharmaceuticals market.

Which Segment Accounts For The Largest Share In The Artificial Intelligence (AI) In Biopharmaceuticals Market?

The artificial intelligence (ai) in biopharmaceuticals market covered in this report is segmented –

1) By Offering: Hardware, Software, Services

2) By Deployment: Cloud, On-Premises

3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies

4) By Application: Business Process And Supply Chain, Drug Discovery, Medical Imaging And Diagnostics, Precision Medicine

5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes

Subsegments:

1) By Hardware: High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions

2) By Software: Drug Discovery Platforms, Clinical Trial Management Software, Predictive Analytics Tools, Natural Language Processing Solutions

3) By Services: Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services

Which Long-Term Trends Will Play A Crucial Role In The Artificial Intelligence (AI) In Biopharmaceuticals Market?

Leading firms in the biopharmaceutical AI sector are focused on innovating advancements such as AI-powered solutions for target and lead identification suite, with an aim to expedite drug discovery process and precision medicine thereby transforming life sciences organizations. These solutions involve a range of novel methods for developing new drugs and customizing treatments for individual patients. For example, in May 2023, US-based cloud computing service provider Google LLC, introduced two new AI-driven tools – the target and lead identification suites, designed to assist researchers in predicting and understanding the protein structures, a primary aspect of drug development. Furthermore, this suite is intended to aid researchers in the ingestion, storage, analysis, and sharing of a large amount of genomic data, critical for precision medicine. By streamlining the drug discovery process, reducing costs, and accelerating the time to market for new treatments, these tools play a significant role. Their aim is to revolutionize drug development by providing efficient data management, precise protein structure predictions, advanced genomic analysis abilities, and ultimately enhance patient outcomes.

Which Companies Hold A Competitive Edge In The 323 Market?

Major companies operating in the artificial intelligence (AI) in biopharmaceuticals market are Apple Inc., Google LLC, Microsoft Corporation, Tencent Holdings Limited, Amazon Web Services Inc., International Business Machines Corporation, Exscientia Limited, NVIDIA Corporation, Amgen Inc., DeepMind Technologies Limited, Schrödinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

Which Region Is Forecasted To Lead The Artificial Intelligence (AI) In Biopharmaceuticals Market In The Coming Years?

North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=14251&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model